Egnyte Creates Egnyte for Life Sciences Platform

November 19, 2020

Egnyte has announced Egnyte for Life Sciences, a purpose-built platform to serve those advancing the science of health. Egnyte’s solution aims to help biotech, medical device, and diagnostics companies accomplish three outcomes: meeting regulatory compliance standards, expedite data sharing and collaboration, and secure essential intellectual property.

The platform provides document management capabilities to facilitate intra- and inter-institutional collaboration while maintaining compliance with FDA 21 CFR Part 11 directives.

Egnyte is also announcing the formation of a Life Sciences Advisory Board to shape its offerings and go-to-market strategy in the industry.

Read the full release, here.

Related Content:

News